INTERNATIONAL PATENT: BEIJING BIOSTARGEN BIOTECHNOLOGY CO., LTD, 北京星基贝勤生物科技有限公司 FILES APPLICATION FOR "BISPECIFIC ANTIBODY TARGETING EGFR AND AXL, DRUG CONJUGATE THEREOF AND USE THEREOF"

Posted On: 2025-09-28

GENEVA, Sept. 28 -- BEIJING BIOSTARGEN BIOTECHNOLOGY CO., LTD (Room 401, Building 27, #20 Changheng Road, Beijing Economic And Technological Development AreaDaxing District, Beijing 102615), 北京星基贝勤生物科技有限公司 (中国北京市大兴区北京经济技术开发区长恒路20号院27号楼A401室) filed a patent application (PCT/CN2024/082882) for "BISPECIFIC ANTIBODY TARGETING EGFR AND AXL, DRUG CONJUGATE THEREOF, AND USE THEREOF" on Mar 21, 2024. With publication no. WO/2025/194412, the details related to the patent applicatio...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: BEIJING BIOSTARGEN BIOTECHNOLOGY CO., LTD, 北京星基贝勤生物科技有限公司 FILES APPLICATION FOR "BISPECIFIC ANTIBODY TARGETING EGFR AND AXL, DRUG CONJUGATE THEREOF AND USE THEREOF"